Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has voiced its support and appreciation for Health Canada’s recently announced Special Access Programme (“SAP”) for psilocybin-assisted psychotherapy inclusion. The government entity recently announced its intent to revise the SAP and other related regulations to allow limited uses of psilocybin-assisted psychotherapeutic treatments. The SAP revision may open the door to new medical applications in the mental health space and support the progress of advanced research initiatives, including ongoing clinical trials evaluating psilocybin-assisted psychotherapy.
The proposed SAP update may also positively impact Pure Extracts application to Health Canada for a Dealers Licence under the Controlled Drugs and Substances Act (“CDSA”). “The Special Access Programme may prove to be the tipping point and fundamental milestone event that eventually transforms an entire segment of the medical community’s outlook towards the treatment of mental health conditions,” said Pure Extracts CEO Ben Nikolaevsky in the press release. “With greater and more open access to trials, researchers can move towards larger and more comprehensive studies eventually including thousands of patient candidates. . . Exact formulations and high-quality products will be required, and that is fundamentally the sort of work we understand and excel at.”
To view the full press release, visit https://ibn.fm/CuOLz
About Pure Extracts Technologies Corp.
Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On Sept. 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act. The company’s stock began trading on the Canadian Securities Exchange (CSE) on Nov. 5, 2020. For more information about the company, please visit www.PureExtractsCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.